نتایج جستجو برای: fgfr

تعداد نتایج: 1529  

2014
Murry W. Wynes Trista K. Hinz Dexiang Gao Michael Martini Lindsay A. Marek Kathryn E. Ware Michael G. Edwards Sven Perner Barbara A. Helfrich Rafal Dziadziuszko Jacek Jassem Szymon Wojtylak Aleksandra Sejda Joseph M. Gozgit Paul A. Bunn D. Ross Camidge Aik-Choon Tan Fred R. Hirsch Lynn E. Heasley

Purpose: FGFR1 gene copy number (GCN) is being evaluated as a biomarker for FGFR tyrosine kinase inhibitor (TKI) response in squamous cell lung cancers (SCC). The exclusive use of FGFR1 GCN for predicting FGFR TKI sensitivity assumes increased GCN is the only mechanism for biologically relevant increases in FGFR1 signaling. Herein, we tested whether FGFR1mRNA and protein expressionmay serve as ...

Journal: :Cardiovascular research 2011
Lydia W T Cheung Kar Wah Leung Chris K C Wong Ricky N S Wong Alice S T Wong

AIMS Ginsenoside-Rg1, the most prevalent active constituent of Panax ginseng, has been shown to possess potent pro-angiogenic properties and therefore poses special interest for the development as a novel modality for angiotherapy. Rg1 can activate the glucocorticoid receptor (GR). However, the mechanism that transmits these pro-angiogenic effects is still unclear. METHODS AND RESULTS By usin...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2005
Peetra Ulrica Magnusson Roberto Ronca Patrizia Dell'Era Pia Carlstedt Lars Jakobsson Juha Partanen Anna Dimberg Lena Claesson-Welsh

OBJECTIVE The purpose of this study was to clarify the role of fibroblast growth factors (FGFs) and FGF receptors (FGFRs) in hematopoietic/endothelial development. METHODS AND RESULTS Using several different FGFR-1-specific antibodies and FGFR-1 promoter-driven LacZ activity, we show that FGFR-1 is expressed and active as a tyrosine kinase in a subpopulation of endothelial cells (approximatel...

2013
Katherine R. Singleton Jihye Kim Trista K. Hinz Lindsay A. Marek Matias Casás-Selves Clark Hatheway Aik Choon Tan James DeGregori Lynn E. Heasley

Our laboratory has previously shown that some gefitinibinsensitive head and neck squamous cell carcinoma (HNSCC) cell lines exhibit dominant autocrine fibroblast growth factor receptor (FGFR) signaling. Herein, we deployed a wholegenome loss-of-function screen to identify genes whose knockdown potentiated the inhibitory effect of the FGFR inhibitor, AZ8010, in HNSCC cell lines. Three HNSCC cell...

Journal: :Molecular cancer therapeutics 2014
Yoshito Nakanishi Nukinori Akiyama Toshiyuki Tsukaguchi Toshihiko Fujii Kiyoaki Sakata Hitoshi Sase Takehito Isobe Kenji Morikami Hidetoshi Shindoh Toshiyuki Mio Hirosato Ebiike Naoki Taka Yuko Aoki Nobuya Ishii

The FGF receptors (FGFR) are tyrosine kinases that are constitutively activated in a subset of tumors by genetic alterations such as gene amplifications, point mutations, or chromosomal translocations/rearrangements. Recently, small-molecule inhibitors that can inhibit the FGFR family as well as the VEGF receptor (VEGFR) or platelet-derived growth factor receptor (PDGFR) family displayed clinic...

Journal: :Cancer discovery 2013
Maria Teresa Herrera-Abreu Alex Pearson James Campbell Steve D Shnyder Margaret A Knowles Alan Ashworth Nicholas C Turner

UNLABELLED Activation of fibroblast growth factor receptors (FGFR) is a common oncogenic event. Little is known about the determinants of sensitivity to FGFR inhibition and how these may vary between different oncogenic FGFRs. Using parallel RNA interference (RNAi) genetic screens, we show that the EGF receptor (EGFR) limits sensitivity to FGFR inhibition in FGFR3-mutant and -translocated cell ...

Journal: :Frontiers in bioscience 2018
Toshiyuki Ishiwata

Types 1-4 of fibroblast growth factor receptors (FGFR) are all expressed in various cancers. Because of its prominent role in carcinogenesis and cancer progression, FGFR-2, is being considered as a novel target in cancer treatment. Owing to the alternative splicing of its extracellular domain, FGFR-2 exists in two variants: IIIb and IIIc. FGFR-2 IIIb is mainly expressed in normal epithelial cel...

Journal: :Circulation research 2005
Esther Millette Bernhard H Rauch Olivier Defawe Richard D Kenagy Guenter Daum Alexander W Clowes

We have shown that the G protein-coupled receptor (GPCR) agonists, thrombin and Factor Xa, stimulate smooth muscle cell (SMC) proliferation through transactivation of the EGF receptor (EGFR) or the FGF receptor (FGFR), both of which are tyrosine kinase receptors. In the present study, we investigated whether platelet-derived growth factor (PDGF), a tyrosine kinase receptor agonist, might transa...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2000
U Pirvola B Spencer-Dene L Xing-Qun P Kettunen I Thesleff B Fritzsch C Dickson J Ylikoski

Interactions between FGF10 and the IIIb isoform of FGFR-2 appear to be crucial for the induction and growth of several organs, particularly those that involve budding morphogenesis. We determined their expression patterns in the inner ear and analyzed the inner ear phenotype of mice specifically deleted for the IIIb isoform of FGFR-2. FGF10 and FGFR-2(IIIb) mRNAs showed distinct, largely nonove...

Journal: :Cancer research 1992
E Armstrong S Vainikka J Partanen J Korhonen R Alitalo

We have previously cloned from K562 leukemia cells two novel fibroblast growth factor receptors (FGFR-3 and FGFR-4; J. Partanen et al., EMBO J., 10: 1347-1354, 1991). Here we have analyzed the mRNA expression of four different FGFRs, including the two novel genes in human leukemia cell lines. We show FGFR-1, FGFR-3, and FGFR-4 mRNAs in several leukemia cell lines at levels similar to those in s...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید